Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)
Hong Kong · Delayed Price · Currency is HKD 28.14
-3.46 (-10.95%)
Jul 28, 2026, 4:08 PM HKT
Shaanxi Micot Pharmaceutical Technology Company Description
Shaanxi Micot Pharmaceutical Technology Co., Ltd. engages in discovery, development and commercialization of bi-/multi-specific peptide drugs.
The company engages in discovery, development and commercialization of bi-/multi-specific peptide drugs for the treatment of metabolic diseases as well as for cancer, cardiovascular, cerebrovascular, and neurological systemic diseases.
The company was founded in founded in 2007 and is headquartered in Xi'an, China.
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
| Country | China |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 558 |
| CEO | Bing Wang |
Contact Details
Address: Building 6 Xi'an China | |
| Website | micot.cn |
Stock Details
| Ticker Symbol | 2335 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100007Q79 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Bing Wang | Founder, Executive Chairman and Chief Executive Officer |
| Dr. Weiping Yu | Senior Vice President and Executive Director |
| Ran Zou | Chief Financial Officer and Joint Company Secretary |
| Zhi Yu | Chief Operating Officer |
| Xiangling Wang | Chief Medical Officer |
| Yee Lam Chan | Joint Company Secretary |